NasdaqGM:RXSTMedical Equipment
RxSight (RXST) Stock Faces Margin Strain After Guidance Withdrawal
RxSight walked into this quarter with a stock that had been roughly flat over the past week and modestly higher over the past month. The immediate reaction told a different story. The share price slipped about 3% to US$6.08 after the Q2 release, as investors focused on pressure in the income statement rather than the long runway often associated with its light adjustable lens technology.
The headline from these earnings is margin and loss pressure. Revenue for Q2 came in at US$33.7m while the...